The stock of Novartis AG (NVS) has seen a -2.56% decrease in the past week, with a -4.64% drop in the past month, and a 14.20% flourish in the past quarter. The volatility ratio for the week is 1.11%, and the volatility levels for the past 30 days are at 1.04% for NVS. The simple moving average for the past 20 days is -4.80% for NVS’s stock, with a 11.55% simple moving average for the past 200 days.
Is It Worth Investing in Novartis AG (NYSE: NVS) Right Now?
Novartis AG (NYSE: NVS) has a price-to-earnings ratio that is above its average at 30.10x. and a 36-month beta value of 0.54. Opinions on the stock are mixed, with 8 analysts rating it as a “buy,” 1 as “overweight,” 9 as “hold,” and 3 as “sell.”
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Sponsored
The average price predicted for Novartis AG (NVS) by analysts is $109.16, which is $10.97 above the current market price. The public float for NVS is 2.10B, and at present, short sellers hold a 0.20% of that float. On May 26, 2023, the average trading volume of NVS was 2.10M shares.
NVS) stock’s latest price update
The stock of Novartis AG (NYSE: NVS) has decreased by -2.25 when compared to last closing price of 100.03. Despite this, the company has experienced a -2.56% fall in its stock price over the last five trading sessions. Barron’s reported on 05/19/23 that Novartis Dropping Some Cancer Drugs From Pipeline
NVS Trading at 1.17% from the 50-Day Moving Average
After a stumble in the market that brought NVS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -7.37% of loss for the given period.
Volatility was left at 1.04%, however, over the last 30 days, the volatility rate increased by 1.11%, as shares sank -4.74% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +19.10% upper at present.
During the last 5 trading sessions, NVS fell by -2.56%, which changed the moving average for the period of 200-days by +12.20% in comparison to the 20-day moving average, which settled at $102.47. In addition, Novartis AG saw 7.78% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for NVS
Current profitability levels for the company are sitting at:
- +24.26 for the present operating margin
- +69.72 for the gross margin
The net margin for Novartis AG stands at +13.76. The total capital return value is set at 13.71, while invested capital returns managed to touch 8.35. Equity return is now at value 12.00, with 6.00 for asset returns.
Based on Novartis AG (NVS), the company’s capital structure generated 47.03 points at debt to equity in total, while total debt to capital is 31.99. Total debt to assets is 22.92, with long-term debt to equity ratio resting at 36.71. Finally, the long-term debt to capital ratio is 24.96.
When we switch over and look at the enterprise to sales, we see a ratio of 3.88, with the company’s debt to enterprise value settled at 0.13. The receivables turnover for the company is 5.92 and the total asset turnover is 0.41. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.29.
Conclusion
To sum up, Novartis AG (NVS) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
